Concepedia

Stacy L. Moulder

SL

98

Publications

6.4K

Citations

39

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California San Diego

Baylor College of Medicine

Moffitt Cancer Center

University of Pennsylvania

Stacy L. Moulder is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

2001–2024

98

Publications

98

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

W. Fraser Symmans, Caimiao Wei, Rebekah Gould et al. · Journal of Clinical Oncology · 2017 · 687 citations · Full text

, , +14

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

Stacy L. Moulder, F. Michael Yakes, Senthil K. Muthuswamy et al. · PubMed · 2001 · 548 citations

, , +15

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 543 citations · Full text

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 453 citations · Full text

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 207 citations · Full text

Rows per page

1–5 of 98